Coronary Sinus Narrowing for the Treatment of Patients With Angina and Evidence of Microvascular Dysfunction: A

Maayan Konigstein1, Itamar Loewenstein1, Ophir Freund2

  • 1Department of Cardiology, Tel Aviv Sourasky University Medical Center (Ichilov), Tel Aviv, Israel; Gray Faculty of Medical and Health Sciences, Tel Aviv University, Tel Aviv, Israel.

Insights

Coronary sinus Reducer implantation improved microvascular function and quality of life in patients with refractory angina and coronary microvascular dysfunction (CMD). This therapy offers significant relief for challenging angina cases.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Vascular Biology

Background:

  • Coronary microvascular dysfunction (CMD) causes refractory angina, a challenging clinical condition.
  • Coronary sinus Reducer implantation is a recognized therapy for obstructive coronary artery disease (CAD).
  • This study investigates the Reducer's efficacy in patients with angina and CMD.

Purpose of the Study:

  • To evaluate the impact of Reducer implantation on microvascular function in patients with angina and CMD.
  • To assess improvements in angina severity, functional capacity, and quality of life post-implantation.

Main Methods:

  • Forty patients with refractory angina, non-obstructive CAD, and CMD underwent Reducer implantation.
  • Invasive microvascular function tests (IMR, CFR, RRR, MRR) were performed at baseline and 4 months.
  • Angina symptoms (CCS class), functional capacity (6mWT), and quality of life (SAQ) were assessed pre- and post-procedure.

Main Results:

  • Significant improvements were observed in IMR, CFR, RRR, and MRR at 4 months post-implantation (p<0.001).
  • Canadian Cardiovascular Society (CCS) class improved from III to II.
  • Seattle Angina Questionnaire (SAQ) scores and 6-minute walk test (6mWT) distance showed significant improvements (p<0.05).

Conclusions:

  • Reducer implantation effectively enhances coronary microvascular function.
  • The procedure leads to significant reductions in angina symptoms.
  • Patients experience improved functional capacity and quality of life after Reducer implantation.
Abstract

Related Concept Videos

Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
Angina I: Introduction01:30

Angina I: Introduction

Definition and Symptoms: Angina (angina pectoris) is chest pain or discomfort caused by myocardial ischemia, which occurs when the heart muscle receives insufficient oxygen-rich blood. It typically manifests as pressing, squeezing, or crushing sensations in the chest and may radiate to the shoulders, arms, neck, jaw, or back.Primary Cause: In a healthy state, the coronary arteries can dilate (widen) to increase blood flow and meet the increased oxygen demand during physical activity or...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Angina III: Clinical Manifestations and Assessment01:29

Angina III: Clinical Manifestations and Assessment

Angina manifests as chest pain, tightness, or squeezing discomfort typically located behind the breastbone. It can radiate to the neck, jaw, shoulders, and inner aspects of the upper arms, most commonly the left arm. Patients may experience shortness of breath, fatigue, profuse sweating, dizziness, indigestion, heartburn, palpitations, anxiety, and vomiting as accompanying symptoms. This pain often lasts a few minutes and is triggered by physical exertion, emotional stress, heavy meals, or cold...